Anticoagulant and antiplatelet medications.
Chevoya
Lynne
L
Housholder-Hughes
Susan
S
D000925:Anticoagulants / Q000009:adverse effects*; D016903:Drug Monitoring / Q000379:methods*; D000077542:Eptifibatide; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006801:Humans; D010314:Partial Thromboplastin Time; D010455:Peptides / Q000009:adverse effects; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000139:chemically induced
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D000077542:Eptifibatide